Key Points

A Close Look at Cancer Control
in Latin America
The Obstacles?
The Goals?
• Comprehensive Healthcare = universal coverage + holistic care
•
Access to the healthcare system
•
Time between diagnosis and treatment
•
Individualized information, appropriate for the patient
information for civil society
•B
etter registries and surveillance systems to monitor
the disease
•
{
LACK OF
•B
etter training for healthcare professionals and more
Early detection and adequate treatment with best
practice guidelines
• Fears and uncertainty of the patient
• Stigma for survivors
• Waiting times
• Bureaucratic obstacles
• Conflicts of interest and political
- Accessible and easy-to-read information
- Treatment continuity and adherence
- Holistic centers
- Patient empowerment
- Training of specialists
- Timely medical care
- Reliable registries
- Involvement of civil organizations
- Strategic planning
- Investment and resources (economic and human)
- More cancer research
- Adaptation of actions to cultural standards
How to improve?
Prevention
and Diagnosis
• Dispel the myths
associated with cancer
Treatment and Care
Quality of Life
•
• Emotional, economic,
social and family support
• Active participation of the patient
in disease control strategies
• For the patient: be informed,
give testimony and proactively
exercise your rights
• For institutions and governments:
raise awareness and educate the
general public on risk factors and
healthy lifestyles
• Vaccination programs
• Access to controlled drugs
• Multidisciplinary support
•R
ehabilitation and reinsertion
into the job market
• Price controls
Evaluation mechanisms
t
n
s
i
o
P
y
e
K
Reinforce aspects
associated with early
detection of the disease
• Strengthen the education of
healthcare professionals, patient
groups and health advocates on
strategies for cancer screening and
early detection
• Develop processes oriented towards early
diagnosis (primary and intermediate levels of care)
•C
ontrol of symptoms and pain
• Adequate infrastructure
• Safe treatments and insurance
policies that cover them
•
1
HojaDatos_vertical_eng.indd 1
Bureaucratic obstacles
2
Improve access
to treatment
• Ensure access to
treatments within the
healthcare systems in
the right way and in a
timely manner
• Disability support and
compensation programs
• Tax breaks for patients
• Telemedicine
• Political commitment
and international support
3
Promote holistic care
and treatment
•D
efine best practice standards, protocols
or guidelines for diagnosis and treatment
that are adapted to Latin America
• Promote multidisciplinary support to
guarantee holistic care and treatment
• Introduce and support access to palliative
care for cancer patients as public policy
11/26/14 4:10 PM
Latin American
Cancer Observatory
MEMBERS
• Eduardo Cazap,
UICC/SLACOM, Argentina
• Ignacio Zervino,
Fundación ACIAPO, Argentina
• Diego Paonessa,
Liga Argentina de Lucha
Emerged from the
Contra el Cáncer, Argentina
“Forum to Improve Cancer Control
•G
abriel Novick,
Swiss Medical Group, Argentina
in Latin America”
•P
ablo Sitic Vargas,
Instituto Oncológico del Oriente
A conference jointly convened by UICC and
Boliviano, Bolivia
SLACOM in May 2014 in Bogota, Colombia.
• Mauricio Magalhães Costa, Federación
Latinoamericana de Mastología, Brazil
• Stephen Doral Stefani, Instituto do Cancer
medical experts and representatives
Mãe de Deus, Brazil
from patient associations from countries
• Luciana Holtz, Instituto Oncoguia, Brazil
of Latin America.
• Piga Fernández, Alianza GIST - Fundación GIST, Chile
• Jorge Madrid, FLASCA, Chile
To discuss the current state of
• Jairo Becerra, Fundación GIST, Colombia
cancer control in the region, promoting
• Adriana Garzón, Fundación Simmon, Colombia
multi-sectorial knowledge sharing and
• Raúl Murillo Moreno, Instituto Nacional de
Cancerología, Colombia
collaboration among key actors in
the area of oncology.
• Mayra Galindo, Asociación Mexicana de Lucha Contra
el Cáncer, Mexico
• Abelardo Meneses García, Instituto Nacional de
Cancerología, Mexico
• José León Duarte, Instituto Nacional del Cáncer, Paraguay
Note: The meeting was supported
• Eva María Ruiz de Castilla Yabar, Esperantra, Peru
by an unrestricted grant from
• José Atias, ASAPHE, Venezuela
Bayer HealthCare.
• Yihad Khalek, Sociedad Venezolana de Oncología, Venezuela
19
9
GIST Chile
HojaDatos_vertical_eng.indd 2
11/26/14 4:10 PM